HDAC2 expression was found to be abnormal in cancer cells, and HDAC2 inhibitors suppressed cell motility, invasion, and proliferation, as well as causing cell death, in gastric cancer cells (Kim et al., 2013). This evidence concerns the gene HDAC2 and gastric cancer.